Publication | Closed Access
A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer
66
Citations
19
References
2019
Year
MedicinePharmacologyGynecologyAnti-cancer AgentCancer TreatmentOncologyTumor BiologyOvarian Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1